CORDENPHARMA COLORADO (US) Home >> Facilities >> CordenPharma Colorado (US) HIGHLY POTENT API VIDEO CORDENPHARMA 15 YEAR ANNIVERSARY CORE CAPABILITIES >> Development & manufacturing of advanced intermediates & chemically synthesized APIs >> Focus on synthetic peptides, highly potent cytotoxic and non-cytotoxic APIs >> Large-scale peptide production >> Manufacture of high volume small molecule APIs >> Green manufacturing (green solvent, recycling concept for upstream & downstream solvent for peptides) CAPACITIES READ FACT SHEET COMPLIANCE >> Good inspection history with the FDA, last inspection 2019 >> No violations on any DEA Inspections >> No violations on Colorado Board of Pharmacy inspections 2019 SHE REGULATORY INSPECTIONS >> US EPA Hazardous Waste Leak Detection and Repair Inspection: One finding >> State of Colorado Air Permit Inspection (Federal Title V Permit): No findings >> State of Colorado Hazardous Waste Inspection: No findings >> City of Boulder Industrial Pretreatment Inspection (Waste Water): No findings >> Boulder County (Ozone Depleting Substances): No findings >> Boulder Fire Department: No findings CordenPharma Colorado Environmental Programs Status Report RELATED PRODUCTS & PLATFORMS APIs >> Small Molecules >> Highly Potent & Oncology >> Peptides >> Lipids & Carbohydrates >> Generic API Portfolio >> API Support Services Drug Products >> Oral Formulation Tablets & Capsules >> Sterile Liquids (Non-Potent) >> Sterile Liquids (Highly Potent) Technology Platforms Peptides Lipids & Carbohydrates Highly Potent & Oncology Small Molecules FACILITY LEGACY CordenPharma Colorado is a world leader in the development and manufacturing of chemically synthesized peptide APIs. Starting as a technology-based contract manufacturing business in 1946, it has contributed important technical advances to API manufacturing, most recently in the fields of highly active compounds and peptide synthesis. The facility is registered globally for producing four APIs and several intermediates. In addition, it has supplied clinical trials in a large number of small molecule and peptide projects, and developed second generation processes for high volume small molecules. As a former facility of Roche, CordenPharma Colorado brings expertise in peptide and small molecule manufacturing which has been realized through significant investments in advanced chemical process equipment and state-of-the-art environmental facilities and infrastructure. HISTORY >> 1946 – 1965: Arapahoe Chemicals founded in Boulder with a focus on producing fine organic chemicals >> 1965 – 1994: Acquired by Syntex Corporation, a company founded in Mexico City with a focus on oral contraceptives. Boulder production focused on Naprosyn® and highly active compounds >> 1994 – 2011: Acquired by Roche, a global healthcare company based in Basel, Switzerland. Boulder production focused on peptides, highly active compounds and complex small molecules >> 2011: Acquired by ICIG to become CordenPharma Colorado Keyboard shortcuts Map data ©2021 Terms of Use Report a map error View in Google Maps Managing Director Brian McCudden Corden Pharma Colorado 2075 55th Street Boulder, Colorado 80301 Phone: +1 (303) 442 1926 Fax: +1 (303) 938 6413 Email Human Resources OPEN JOBS NEWS & PRESS EVENTS RESOURCE LIBRARY CAREERS ABOUT US CONTACT US TERMS AND CONDITIONS PRIVACY POLICY MEDIA CONTACT IMPRESSUM SITE MAP COVID-19 UPDATE Also of Interest: Peptides Company Sterile Injectables New GMP Peptide Expansion in Colorado ©2021 CordenPharma International Website created by Advanta Advertising, LLC The CordenPharma Website is set to allow the use of cookies. Cookies help us to give you the best experience on our website. By clicking Accept or continuing to use the site, you agree to use our cookies. If you decline we will not track your information but your browsing experience might be limited. For more information on our Privacy Policy click here. ACCEPTDECLINE